DOD Biotech Bilan de santé
Santé financière contrôle des critères 5/6
DOD Biotech has a total shareholder equity of THB874.9M and total debt of THB87.1M, which brings its debt-to-equity ratio to 10%. Its total assets and total liabilities are THB1.2B and THB328.8M respectively.
Informations clés
10.0%
Ratio d'endettement
฿87.08m
Dette
| Ratio de couverture des intérêts | n/a |
| Argent liquide | ฿75.71m |
| Fonds propres | ฿874.92m |
| Total du passif | ฿328.82m |
| Total des actifs | ฿1.20b |
Mises à jour récentes de la santé financière
Pas de mise à jour
Recent updates
Analyse de la situation financière
Passif à court terme: DOD's short term assets (THB471.9M) exceed its short term liabilities (THB242.1M).
Passif à long terme: DOD's short term assets (THB471.9M) exceed its long term liabilities (THB86.7M).
Historique et analyse du ratio d'endettement
Niveau d'endettement: DOD's net debt to equity ratio (1.3%) is considered satisfactory.
Réduire la dette: DOD's debt to equity ratio has reduced from 10.4% to 10% over the past 5 years.
Couverture de la dette: DOD's debt is well covered by operating cash flow (66.1%).
Couverture des intérêts: Insufficient data to determine if DOD's interest payments on its debt are well covered by EBIT.